Trial intelligence / Profile preview

Abilify in Asian pediatric patients with autism spectrum disorder

NCT02069977Phase 4Unknown

Start
Feb 2014
Primary completion
Feb 2016
Modality
Small Molecules
Countries
3
01

Overview

A Phase 4 trial of aripiprazole in Autism Spectrum Disorder (ASD). Status: unknown.

02

Drugs

aripiprazole
03

Conditions

Autism Spectrum Disorder (ASD)

Beyond the preview

Go deeper on NCT02069977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02069977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call